NMD PHARMA NEUROMUSCULAR DISORDERS Trademark

Trademark Overview

On Tuesday, July 15, 2025, a trademark application was filed for NMD PHARMA NEUROMUSCULAR DISORDERS with the United States Patent and Trademark Office. The USPTO has given the NMD PHARMA NEUROMUSCULAR DISORDERS trademark a serial number of 79432114. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 4, 2025. This trademark is owned by NMD Pharma A/S. The NMD PHARMA NEUROMUSCULAR DISORDERS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care.

Preparations for pharmaceutical purposes, preparations for medical purposes, chemical-pharmaceutical preparations, diagnostic preparations for medical purposes, reagents for medical purposes, preparations for analysis for medical purposes; pharmaceutical and medical preparations for the treatment of rare and genetic diseases; pharmaceutical and medical preparations for the treatment of neurodegenerative diseases; pharmaceutical and medical preparations for the treatment of neuromuscular disorders; pharmaceutical and medical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders, pharmaceutical and medical preparations for acute hospital care
nmd pharma neuromuscular disorders

General Information

Serial Number79432114
Word MarkNMD PHARMA NEUROMUSCULAR DISORDERS
Filing DateTuesday, July 15, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, September 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care.
Pseudo MarkNEUROMUSCULAR DISORDERS PHARMA NEUROMUSCULAR DISORDERS
Goods and ServicesPreparations for pharmaceutical purposes, preparations for medical purposes, chemical-pharmaceutical preparations, diagnostic preparations for medical purposes, reagents for medical purposes, preparations for analysis for medical purposes; pharmaceutical and medical preparations for the treatment of rare and genetic diseases; pharmaceutical and medical preparations for the treatment of neurodegenerative diseases; pharmaceutical and medical preparations for the treatment of neuromuscular disorders; pharmaceutical and medical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders, pharmaceutical and medical preparations for acute hospital care

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 8, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 8, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNMD Pharma A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events

Event DateEvent Description
Thursday, September 4, 2025SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Saturday, November 8, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, November 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 10, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

disorders neuromuscular pharma medical preparations pharmaceutical development purposes treatments research diseases